Brian M Alexander

18PUBLICATIONS
172CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersIndustrial and employee relationsEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Feb 19, 2025
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma.

Veronica Rendo, Eudocia Q Lee, Connor Bossi

|Jan 17, 2025
Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma.

Eudocia Q Lee, Brian M Alexander, Carlos G Romo

|Sep 18, 2023
Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization.

Rifaquat Rahman, Lorenzo Trippa, Eudocia Q Lee

|Mar 20, 2023
Accessible Data Collections for Improved Decision Making in Neuro-Oncology Clinical Trials.

Rifaquat Rahman, Steffen Ventz, Robert Redd

|Feb 27, 2023
Validation of Predictive Analyses for Interim Decisions in Clinical Trials.

Alejandra Avalos-Pacheco, Steffen Ventz, Andrea Arfè

|Feb 13, 2023
ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma.

Anne-Florence Blandin, Ross Giglio, Maya Srikanth Graham

Pageof 3